Asosiy kontentga oʻtish
proceeding

Transformation of the clinical-neurological pattern of phenylketonuria in children in Uzbekistan: assessment of the influence of diet therapy initiation timing through retrospective analysis

Munisakhon Gafforova3rd-year Master’s student Department of Neurology, Pediatric Neurology and Medical Genetics, Tashkent State Medical University, Tashkent, UzbekistanGulchehra SadikovaDoctor of Medical Sciences, Professor Tashkent State Medical University, Tashkent, Uzbekistan
2026
ABI

Annotatsiya

Delayed recognition of phenylketonuria (PKU) exposes the developing brain to prolonged phenylalanine (Phe) toxicity. In this retrospective cohort study, the records of 50 children with PKU in Uzbekistan aged 1 month to 15 years were analyzed: diet therapy was started before 3 months of age in 25 and at 3 months or later in 25. Later initiation was associated with more frequent developmental delay (80.0% vs 16.0%; OR 21.00, 95% CI 4.92–89.56; p < 0.001) and seizures (52.0% vs 8.0%; OR 12.46, 95% CI 2.41–64.50; p = 0.001), higher mean blood Phe (578.1 vs 358.9 µmol/L) and a higher neurological score (4.0 vs 1.2 points). Each 100 µmol/L increase in Phe raised the odds of developmental delay 2.65-fold (95% CI 1.50–4.70; AUC 0.84). Earlier initiation of diet therapy is associated with a milder clinical-neurological pattern, which supports universal newborn screening and immediate dietary management.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar